SCHEMBL19211408

SCHEMBL19211408

COc1ncc(N2CC(F)(F)C2)c(-c2c[nH]nn2)n1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 10/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19211376 0.92 RXRA (0.31)
SCHEMBL19211394 0.91 CNR2 (0.36) CNR2
SCHEMBL19211506 0.83
SCHEMBL19211438 0.81 CNR2 (0.33) CNR2
SCHEMBL19211491 0.80 RXRA (0.30)
SCHEMBL19211407 0.78 CNR2 (0.35) CNR2
SCHEMBL19211375 0.70
SCHEMBL19211392 0.70 CNR2 (0.35) CNR2
SCHEMBL29829084 0.64 HSD11B1 (0.35)
SCHEMBL19211505 0.61 PDCD1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414233-A1 SUBSTITUTED 1,2,3-TRIAZOLES AS NR2B-SELECTIVE NMDA MODULATORS Janssen Pharmaceutica NV (BE) 2018-12-19 EP disclosed
WO-2017139428-A1 SUBSTITUTED 1,2,3-TRIAZOLES AS NR2B-SELECTIVE NMDA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-08-17 WO disclosed